Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- Directory of Abstract Indexing for Journals
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 26, which means every article in Journal of Stem Cell Research & Therapy has got 26 average citations.
Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
59 | 65 | 23 | 13 | 36 |
Year wise citations received |
351 | 405 | 380 | 349 | 319 |
| Journal total citations count | 3118 |
| Journal Impact Factor | 1.64 |
| Journal 5 years Impact Factor | 1.70 |
| Journal CiteScore | 11.56 |
| Journal h-index | 26 |
Important citations
Nicolosi PA, Dallatomasina A, Perris R (2015) Theranostic impact of NG2/CSPG4 proteoglycan in cancer. Theranostics 5: 530-544.
Farnedi A, Rossi S, Bertani N, Gulli M, Silini EM, et al. (2015) Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors. BMC cancer 15: 352.
Atkinson K, Timmins N, Kiel G, Heazlewood C, Doran M, et al. (2017) Closed automated largeâ€scale bioreactors for manufacturing mesenchymal stromal cells for clinical use. The Biology and Therapeutic Application of Mesenchymal Cells 616-618.
Haack-Sørensen M, Follin B, Juhl M, Brorsen SK, Søndergaard RH, et al. (2016) Culture expansion of adipose derived stromal cells. A closed automated Quantum Cell Expansion System compared with manual flask-based culture. Journal of Translational Medicine 14: 319.
Lambrechts T, Sonnaert M, Schrooten J, Luyten FP, Aerts JM, et al. (2016) Large-Scale Mesenchymal Stem/Stromal Cell Expansion: A Visualization Tool for Bioprocess Comparison. Tissue Engineering Part B: Reviews 22: 485-498.
António M, Fernandes-Platzgummer A, da Silva CL, Cabral JM (2016) Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells. Journal of Biotechnology 236: 88-109.
Lambrechts T, Papantoniou I, Rice B, Schrooten J, Luyten FP, et al. (2016) Large-scale progenitor cell expansion for multiple donors in a monitored hollow fibre bioreactor. Cytotherapy 18: 1219-1233.
Lechanteur C, Briquet A, Giet O, Delloye O, Baudoux E, et al. (2016) Clinical-scale expansion of mesenchymal stromal cells: a large banking experience. Journal of translational medicine 14:145.
Cai R, Nakamoto T, Hoshiba T, Kawazoe N, Chen G (2016) Matrices secreted during simultaneous osteogenesis and adipogenesis of mesenchymal stem cells affect stem cells differentiation. Acta biomaterialia 35: 185-193.
Deng P, Chen Y, Ji N, Lin Y, Yuan Q, et al.(2015) Cysteine dioxygenase type 1 promotes adipogenesis via interaction with peroxisome proliferator-activated receptor gamma. Biochemical and biophysical research communications 458: 123-127.
Deng P, Chen Y, Ji N, Lin Y, Yuan Q, et al. (2015) Cysteine dioxygenase type 1 promotes adipogenesis via interaction with peroxisome proliferator-activated receptor gamma. Biochemical and biophysical research communications 458: 123-127.
Rahmalita A, Sa’dya NA, Putra A (2016) Pengaruh Pemberian Mesenchymal Stem cell Pada Dosis Maksimal Terhadap Jumlah Endotel Pembuluh Darah Jaringan Pankreas Diabetes Mellitus Tipe 2. PROCEEDING FOKI1: 62-66.
Sudarmastut YT, Sa’dyah NA, Putra A (2016) Pengaruh Pemberian Mesenchymal Stem Cell Pada Dosis Minimal Terhadap Jumlah Endotel Pembuluh Darah Jaringan Pankreas Diabetes Mellitus Tipe 2 Studi Eksperimental In Vivo Dosis Minimal pada Mencit (Mus musculus) Hiperglikemi yang diinduksi Streptozotocin. PROCEEDING FOKI 1: 67-70.
Chala TS, Ali GY (2016) Recent advance in diabetes therapy: pancreatic beta cell regeneration approaches. Diabetes Management.
Monfrini M, Donzelli E, Rodriguez-Menendez V, Ballarini E, Carozzi VA, et al. (2017) Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy. Experimental Neurology. 288: 75-84.
Vyas BK, Vyas RB, Ansarullah A, Marathe A, Thadani JM, (2016) Therapeutic Application of Autologous ADMSCS (Adipose Derived Mesenchymal Stem Cells) and Islet like Cell Aggregates (ICAS) Derived from them in Type 1 and 2 Diabetes Mellitus-A Proof of Concept Study. J Stem Cell Res Dev Ther.
Sharma A, Yerra VG, Kumar A (2017) Emerging role of Hippo signalling in pancreatic biology: YAP re-expression and plausible link to islet cell apoptosis and replication. Biochimie133: 56-65.
Peired AJ, Sisti A, Romagnani P (2016) Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence. Stem Cells International
Finelli MJ, Sanchez-Pulido L, Liu KX, Davies KE, Oliver PL (2016) The evolutionarily conserved Tre2/Bub2/Cdc16 (TBC), Lysin motif (LysM), Domain catalytic (TLDc) domain is neuroprotective against oxidative stress. Journal of Biological Chemistry 291: 2751-2763.
Bora CR, Martinez L (2016) Challenges of Quality Testing Program in Cellular Therapies. BAOJ Microbio.